Zurich Cantonal Bank’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
Zurich Cantonal Bank's RDY Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its Dr. Reddy's Laboratories (RDY) stake by 9% in Q2 2026, selling an estimated $7.66K and leaving 5,773 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.
Zurich Cantonal Bank first reported a position in RDY in Q2 2013 and has held it in 37 quarters since. The position peaked at $15.9M in Q3 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Zurich Cantonal Bank held 5,773 shares of Dr. Reddy's Laboratories worth $83.7K as of Q2 2026.
- Zurich Cantonal Bank sold 568 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $7.66K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2423 holding.
- Zurich Cantonal Bank first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 37 quarters since.
- Zurich Cantonal Bank's Dr. Reddy's Laboratories position peaked at $15.9M in Q3 2015.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.